TREM2 and Alzheimer disease: Nano-LC/MS analysis have shown that AD-associated R47H variant of TREM2 increases its terminal glycosylation with complex oligosaccharides in the Golgi apparatus, including the non-high mannose type glycan, and fucosylated-sialylated complex/hybrid type glycans, etc. (Fig. 5).